Multiple Choice
Which statement correctly summarizes the translational studies using mGluR5 agonists to treat Fragile X syndrome?
A) Although mGluR5 agonists did not show promise in treating FXS in animal models, they did have efficacy in clinical trials.
B) Although mGluR5 agonists showed promise in treating FXS in animal models, they did not have efficacy in clinical trials.
C) Although the early mGlurR5 agonists did not improve FXS symptoms, a later drug, basimglurant, did.
D) mGluR5 agonists have been proven to reduce symptoms both in animal models and in people with FXS.
Correct Answer:
Verified
Correct Answer:
Verified
Q26: Explain how the coincidence detection feature of
Q27: The NMDA receptor<br>A) selectively opens channels for
Q28: Explain how the GABA<sub>B</sub> receptor is structurally
Q29: GABA<sub>B</sub> receptor agonists are clinically useful for
Q30: Glutamate differs from other neurotransmitters such as
Q32: Drugs that block GAT-1, such as Gabitril
Q33: After neuronal release, what happens to GABA
Q34: Describe the role of NMDA and AMPA
Q35: Name one GABA<sub>A</sub> receptor agonist and two
Q36: The presence of vesicular glutamate transporters and